Matches in SemOpenAlex for { <https://semopenalex.org/work/W1946192834> ?p ?o ?g. }
- W1946192834 endingPage "1240" @default.
- W1946192834 startingPage "1233" @default.
- W1946192834 abstract "Abstract Background and Aims: Pegylated interferon (PEG‐IFN) α‐2b and ribavirin (RBV) treatment of chronic hepatitis C virus (HCV) infection is associated with a substantially elevated risk of discontinuation. The aim of this study is to evaluate the reason for premature discontinuation during PEG‐IFN α‐2b and RBV treatment due to adverse effects in patients with chronic HCV infection. Methods: A total of 2871 Japanese patients who had chronic HCV infection treated with PEG‐IFN α‐2b and RBV were screened. We prospectively investigated the reasons for premature discontinuation of treatment classified by sex and age, and analyzed the timing of discontinuation. Results: Of the 2871 patients, 250 (8.7%) discontinued treatment because of adverse effects. The main reasons for premature discontinuation were neurovegetative symptoms ( n = 77, 30.8%), depression‐related syndrome ( n = 46, 18.4%), hematologic effects ( n = 41, 16.4%) and dermatologic effects ( n = 27, 10.8%). The rate of discontinuation of treatment for patients aged ≥ 65 years was significantly higher than for patients aged < 65 years, for both men ( P < 0.0001) and women ( P = 0.0121). Moreover, the frequency of discontinuation due to neurovegetative symptoms, depression‐related syndrome, and hematologic effects for men aged ≥ 65 years was significantly higher than for those aged < 65 years ( P = 0.0001, P = 0.0016, and P = 0.0170, respectively), but not for women. Conclusion: Premature discontinuation due to the adverse effects of PEG‐IFN α‐2b and RBV treatment by patients with chronic HCV infection is mainly due to neuropsychiatric symptoms and is more common for older than for younger patients." @default.
- W1946192834 created "2016-06-24" @default.
- W1946192834 creator A5002003443 @default.
- W1946192834 creator A5002436824 @default.
- W1946192834 creator A5015308430 @default.
- W1946192834 creator A5016018624 @default.
- W1946192834 creator A5017442524 @default.
- W1946192834 creator A5018109978 @default.
- W1946192834 creator A5023885160 @default.
- W1946192834 creator A5029531575 @default.
- W1946192834 creator A5031465104 @default.
- W1946192834 creator A5045245886 @default.
- W1946192834 creator A5060667403 @default.
- W1946192834 creator A5068808737 @default.
- W1946192834 creator A5070035652 @default.
- W1946192834 creator A5071111958 @default.
- W1946192834 date "2012-06-19" @default.
- W1946192834 modified "2023-10-17" @default.
- W1946192834 title "Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study" @default.
- W1946192834 cites W1586002888 @default.
- W1946192834 cites W1966509200 @default.
- W1946192834 cites W1969065116 @default.
- W1946192834 cites W1969178220 @default.
- W1946192834 cites W1975620628 @default.
- W1946192834 cites W1975997607 @default.
- W1946192834 cites W1992692012 @default.
- W1946192834 cites W1998976706 @default.
- W1946192834 cites W2000893049 @default.
- W1946192834 cites W2001738443 @default.
- W1946192834 cites W2010281634 @default.
- W1946192834 cites W2018896573 @default.
- W1946192834 cites W2027545702 @default.
- W1946192834 cites W2030438646 @default.
- W1946192834 cites W2051743459 @default.
- W1946192834 cites W2065646699 @default.
- W1946192834 cites W2100485606 @default.
- W1946192834 cites W2122216714 @default.
- W1946192834 cites W2123368323 @default.
- W1946192834 cites W2127685726 @default.
- W1946192834 cites W2128722957 @default.
- W1946192834 cites W2130113454 @default.
- W1946192834 cites W2139943848 @default.
- W1946192834 cites W2141214317 @default.
- W1946192834 cites W2156857913 @default.
- W1946192834 cites W2336799715 @default.
- W1946192834 doi "https://doi.org/10.1111/j.1440-1746.2011.06965.x" @default.
- W1946192834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22098185" @default.
- W1946192834 hasPublicationYear "2012" @default.
- W1946192834 type Work @default.
- W1946192834 sameAs 1946192834 @default.
- W1946192834 citedByCount "35" @default.
- W1946192834 countsByYear W19461928342013 @default.
- W1946192834 countsByYear W19461928342014 @default.
- W1946192834 countsByYear W19461928342015 @default.
- W1946192834 countsByYear W19461928342016 @default.
- W1946192834 countsByYear W19461928342017 @default.
- W1946192834 countsByYear W19461928342018 @default.
- W1946192834 countsByYear W19461928342020 @default.
- W1946192834 countsByYear W19461928342021 @default.
- W1946192834 countsByYear W19461928342023 @default.
- W1946192834 crossrefType "journal-article" @default.
- W1946192834 hasAuthorship W1946192834A5002003443 @default.
- W1946192834 hasAuthorship W1946192834A5002436824 @default.
- W1946192834 hasAuthorship W1946192834A5015308430 @default.
- W1946192834 hasAuthorship W1946192834A5016018624 @default.
- W1946192834 hasAuthorship W1946192834A5017442524 @default.
- W1946192834 hasAuthorship W1946192834A5018109978 @default.
- W1946192834 hasAuthorship W1946192834A5023885160 @default.
- W1946192834 hasAuthorship W1946192834A5029531575 @default.
- W1946192834 hasAuthorship W1946192834A5031465104 @default.
- W1946192834 hasAuthorship W1946192834A5045245886 @default.
- W1946192834 hasAuthorship W1946192834A5060667403 @default.
- W1946192834 hasAuthorship W1946192834A5068808737 @default.
- W1946192834 hasAuthorship W1946192834A5070035652 @default.
- W1946192834 hasAuthorship W1946192834A5071111958 @default.
- W1946192834 hasConcept C126322002 @default.
- W1946192834 hasConcept C139719470 @default.
- W1946192834 hasConcept C162324750 @default.
- W1946192834 hasConcept C197934379 @default.
- W1946192834 hasConcept C203014093 @default.
- W1946192834 hasConcept C2522874641 @default.
- W1946192834 hasConcept C2776408679 @default.
- W1946192834 hasConcept C2776455275 @default.
- W1946192834 hasConcept C2776461080 @default.
- W1946192834 hasConcept C2776867660 @default.
- W1946192834 hasConcept C2778715236 @default.
- W1946192834 hasConcept C2780040827 @default.
- W1946192834 hasConcept C71924100 @default.
- W1946192834 hasConcept C90924648 @default.
- W1946192834 hasConceptScore W1946192834C126322002 @default.
- W1946192834 hasConceptScore W1946192834C139719470 @default.
- W1946192834 hasConceptScore W1946192834C162324750 @default.
- W1946192834 hasConceptScore W1946192834C197934379 @default.
- W1946192834 hasConceptScore W1946192834C203014093 @default.
- W1946192834 hasConceptScore W1946192834C2522874641 @default.
- W1946192834 hasConceptScore W1946192834C2776408679 @default.
- W1946192834 hasConceptScore W1946192834C2776455275 @default.
- W1946192834 hasConceptScore W1946192834C2776461080 @default.